Schedule of Discontinuing Operations from Income Statement and Balance Sheet |
Results
of discontinuing operations were as follows for the three and nine months ended September 30, 2022 and 2021:
Schedule of Discontinuing Operations from Income Statement and Balance Sheet
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
|
Three months ended September 30, |
|
|
Nine months ended September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Revenue |
|
$ |
2,140 |
|
|
$ |
1,251 |
|
|
$ |
5,180 |
|
|
$ |
2,887 |
|
Cost of goods sold |
|
|
1,097 |
|
|
|
952 |
|
|
|
2,477 |
|
|
|
1,901 |
|
General and administrative |
|
|
1,287 |
|
|
|
1,489 |
|
|
|
3,428 |
|
|
|
2,419 |
|
Impairment charge (recovery) of goodwill and intangible assets |
|
|
(388 |
) |
|
|
- |
|
|
|
5,415 |
|
|
|
- |
|
Total operating costs and expenses |
|
|
1,996 |
|
|
|
2,441 |
|
|
|
11,320 |
|
|
|
4,320 |
|
Income (loss) from discontinuing operations |
|
|
144 |
|
|
|
(1,190 |
) |
|
|
(6,140 |
) |
|
|
(1,433 |
) |
Total other (expense) income |
|
|
- |
|
|
|
3 |
|
|
|
3 |
|
|
|
6 |
|
Income (loss) from discontinuing operations before income taxes |
|
|
144 |
|
|
|
(1,187 |
) |
|
|
(6,137 |
) |
|
|
(1,427 |
) |
Income tax benefit |
|
|
40 |
|
|
|
- |
|
|
|
84 |
|
|
|
- |
|
Net income (loss) from discontinuing operations |
|
$ |
184 |
|
|
$ |
(1,187 |
) |
|
$ |
(6,053 |
) |
|
$ |
(1,427 |
) |
Assets
and liabilities of discontinuing operations were as follows as of September 30, 2022 and December 31, 2021:
|
|
September 30, 2022 |
|
|
December 31, 2021 |
|
Accounts receivable |
|
$ |
796 |
|
|
$ |
457 |
|
Other current assets |
|
|
326 |
|
|
|
345 |
|
Assets of discontinuing operations - current |
|
|
1,122 |
|
|
|
802 |
|
|
|
|
|
|
|
|
|
|
Fixed assets, net of accumulated depreciation |
|
|
242 |
|
|
|
163 |
|
Operating lease right-of-use assets |
|
|
844 |
|
|
|
30 |
|
Intangible assets, net |
|
|
5,511 |
|
|
|
8,787 |
|
Goodwill |
|
|
- |
|
|
|
2,164 |
|
Other assets |
|
|
366 |
|
|
|
364 |
|
Assets of discontinuing operations - non-current |
|
|
6,963 |
|
|
|
11,508 |
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
810 |
|
|
$ |
358 |
|
Accrued expense |
|
|
363 |
|
|
|
418 |
|
Obligation under operating lease, current |
|
|
152 |
|
|
|
29 |
|
Obligation under finance lease, current |
|
|
30 |
|
|
|
32 |
|
Deferred revenue |
|
|
1,935 |
|
|
|
1,911 |
|
Taxes payable |
|
|
275 |
|
|
|
365 |
|
Other current liabilities |
|
|
280 |
|
|
|
409 |
|
Liabilities of discontinued operations - current |
|
|
3,845 |
|
|
|
3,522 |
|
|
|
|
|
|
|
|
|
|
Obligations under operating leases, less current |
|
|
709 |
|
|
|
2 |
|
Obligations under finance leases, less current |
|
|
19 |
|
|
|
47 |
|
Liabilities of discontinued operations - non-current |
|
|
728 |
|
|
|
49 |
|
|
Schedule of Intangible Assets |
Intangible
assets consisted of the following as of September 30, 2022 and December 31, 2021:
Schedule of Intangible Assets
|
|
September 30, 2022 |
|
|
December 31, 2021 |
|
Customer relationships |
|
$ |
5,241 |
|
|
$ |
8,000 |
|
Trade name |
|
|
983 |
|
|
|
1,500 |
|
Intangible assets, net |
|
|
6,224 |
|
|
|
9,500 |
|
Less accumulated amortization |
|
|
(713 |
) |
|
|
(713 |
) |
Intangible assets, net |
|
$ |
5,511 |
|
|
$ |
8,787 |
|
|
Schedule of Goodwill Rollforward |
Goodwill
arising from the Merger was solely attributed to the vivoPharm business. The following is a roll forward of goodwill as of and
for the nine months ended September 30, 2022:
Schedule of Goodwill Rollforward
|
|
2022 |
|
|
|
|
|
Beginning balance, January 1 |
|
$ |
2,164 |
|
Purchase price adjustments |
|
|
- |
|
Impairment charge |
|
|
(2,164 |
) |
Ending balance, September 30 |
|
$ |
- |
|
|